» Articles » PMID: 37260746

Secreted ORF8 Induces Monocytic Pro-inflammatory Cytokines Through NLRP3 Pathways in Patients with Severe COVID-19

Abstract

Despite extensive research, the specific factor associated with SARS-CoV-2 infection that mediates the life-threatening inflammatory cytokine response in patients with severe COVID-19 remains unidentified. Herein we demonstrate that the virus-encoded Open Reading Frame 8 (ORF8) protein is abundantly secreted as a glycoprotein and in symptomatic patients with COVID-19. ORF8 specifically binds to the NOD-like receptor family pyrin domain-containing 3 (NLRP3) in CD14 monocytes to induce inflammasomal cytokine/chemokine responses including IL1β, IL8, and CCL2. Levels of ORF8 protein in the blood correlate with severity and disease-specific mortality in patients with acute SARS-CoV-2 infection. Furthermore, the ORF8-induced inflammasome response was readily inhibited by the NLRP3 inhibitor MCC950 . Our study identifies a dominant cause of pathogenesis, its underlying mechanism, and a potential new treatment strategy for severe COVID-19.

Citing Articles

The comprehensive SARS-CoV-2 'hijackome' knowledge base.

Huuskonen S, Liu X, Pohner I, Redchuk T, Salokas K, Lundberg R Cell Discov. 2024; 10(1):125.

PMID: 39653747 PMC: 11628605. DOI: 10.1038/s41421-024-00748-y.


Transplacental SARS-CoV-2 protein ORF8 binds to complement C1q to trigger fetal inflammation.

Azamor T, Familiar-Macedo D, Salem G, Onwubueke C, Melano I, Bian L EMBO J. 2024; 43(22):5494-5529.

PMID: 39390219 PMC: 11574245. DOI: 10.1038/s44318-024-00260-9.


SARS-CoV2 infection in whole lung primarily targets macrophages that display subset-specific responses.

Vu Manh T, Gouin C, de Wolf J, Jouneau L, Pascale F, Bevilacqua C Cell Mol Life Sci. 2024; 81(1):351.

PMID: 39147987 PMC: 11335275. DOI: 10.1007/s00018-024-05322-z.


NLRP3 Inflammasomes: Dual Function in Infectious Diseases.

Li Y, Qiang R, Cao Z, Wu Q, Wang J, Lyu W J Immunol. 2024; 213(4):407-417.

PMID: 39102612 PMC: 11299487. DOI: 10.4049/jimmunol.2300745.


Monocyte response to SARS-CoV-2 protein ORF8 is associated with severe COVID-19 infection in patients with chronic lymphocytic leukemia.

Ruan G, Wu X, Gwin K, Manske M, Abeykoon J, Bhardwaj V Haematologica. 2024; 109(9):2884-2892.

PMID: 38654668 PMC: 11367184. DOI: 10.3324/haematol.2023.284617.

References
1.
Back N, Kanerva K, Kurutihalli V, Yanik A, Ikonen E, Mains R . The endocytic pathways of a secretory granule membrane protein in HEK293 cells: PAM and EGF traverse a dynamic multivesicular body network together. Eur J Cell Biol. 2017; 96(5):407-417. PMC: 5592135. DOI: 10.1016/j.ejcb.2017.03.007. View

2.
Li H, Guan Y, Liang B, Ding P, Hou X, Wei W . Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome. Eur J Pharmacol. 2022; 928:175091. DOI: 10.1016/j.ejphar.2022.175091. View

3.
Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y . Detectable Serum Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load (RNAemia) Is Closely Correlated With Drastically Elevated Interleukin 6 Level in Critically Ill Patients With Coronavirus Disease 2019. Clin Infect Dis. 2020; 71(8):1937-1942. PMC: 7184354. DOI: 10.1093/cid/ciaa449. View

4.
Kyriazopoulou E, Poulakou G, Milionis H, Metallidis S, Adamis G, Tsiakos K . Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med. 2021; 27(10):1752-1760. PMC: 8516650. DOI: 10.1038/s41591-021-01499-z. View

5.
Weinreich D, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R . REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19. N Engl J Med. 2020; 384(3):238-251. PMC: 7781102. DOI: 10.1056/NEJMoa2035002. View